Actuate Therapeutics, Inc. (ACTU)
0.9812
-0.01
(-1.41%)
USD |
NASDAQ |
Sep 18, 16:00
0.98
0.00 (0.00%)
After-Hours: 05:29
Actuate Therapeutics Market Cap : 23.56M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 23.56M |
| September 17, 2026 | 23.90M |
| September 16, 2026 | 23.95M |
| September 15, 2026 | 23.62M |
| September 14, 2026 | 24.73M |
| September 11, 2026 | 25.69M |
| September 10, 2026 | 27.62M |
| September 09, 2026 | 30.26M |
| September 08, 2026 | 32.90M |
| September 04, 2026 | 35.54M |
| September 03, 2026 | 32.90M |
| September 02, 2026 | 31.22M |
| September 01, 2026 | 36.98M |
| August 31, 2026 | 36.50M |
| August 28, 2026 | 39.74M |
| August 27, 2026 | 40.58M |
| August 26, 2026 | 42.74M |
| August 25, 2026 | 37.94M |
| August 24, 2026 | 29.54M |
| August 21, 2026 | 30.50M |
| August 20, 2026 | 29.54M |
| August 19, 2026 | 25.45M |
| August 18, 2026 | 25.21M |
| August 17, 2026 | 23.77M |
| August 14, 2026 | 24.25M |
| Date | Value |
|---|---|
| August 13, 2026 | 23.42M |
| August 12, 2026 | 23.29M |
| August 11, 2026 | 24.25M |
| August 10, 2026 | 24.19M |
| August 07, 2026 | 26.20M |
| August 06, 2026 | 29.17M |
| August 05, 2026 | 26.79M |
| August 04, 2026 | 26.56M |
| August 03, 2026 | 25.13M |
| July 31, 2026 | 26.32M |
| July 30, 2026 | 27.74M |
| July 29, 2026 | 25.61M |
| July 28, 2026 | 25.13M |
| July 27, 2026 | 27.27M |
| July 24, 2026 | 27.98M |
| July 23, 2026 | 29.88M |
| July 22, 2026 | 30.00M |
| July 21, 2026 | 32.01M |
| July 20, 2026 | 33.20M |
| July 17, 2026 | 34.14M |
| July 16, 2026 | 39.36M |
| July 15, 2026 | 40.78M |
| July 14, 2026 | 41.02M |
| July 13, 2026 | 35.57M |
| July 10, 2026 | 28.69M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.048B |
Market Cap Related Metrics
| Price to Book Value | 23.82 |
| Price | 0.9812 |
| Earnings Yield | -90.86% |